{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

Last chance to take part in our stem cell survey!

Anyone can complete our short survey on stem cell research which will help inform the next edition of MS in focus magazine.

read more

Register now for Prague07

Prague07 - Living with MS: Today and Tomorrow, which will be of interest to everyone with a connection to MS, takes place on 10 October 2007 (prior to ECTRIMS) at the Prague Congress Centre, Czech Republic.

read more

back to top

Profile of the Month : June 2008

Sophie Froger

Age: 50
Country: France
Occupation: Former attorney
Year of diagnosis: 2000

"Each day can bring us a few tiny moments of intense happiness."

English Espanol Deutsch Italiano Francais Russian

read more

back to top

The spectrum of neuromyelitis optica

The authors review neuromyelitis optica (NMO), a disease that is sometimes difficult to distinguish from MS. NMO is a severe demyelinating disease which affects the spinal cord and optic nerves.

authors: Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.

source: Lancet Neurol. 2007 Sep;6(9):805-15.

read more

Distinct mechanisms of altered brain activation in patients with multiple sclerosis

The authors, using a recently introduced MRI technique which measures brain activity, compared patterns of activation during cognitive tasks in people with MS and in normal controls. They found that the differences between the two groups were partially due to ongoing compensatory processes in people with MS.

authors: Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D.

source: Neuroimage. 2007 Sep 1;37(3):937-46

read more

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results

This preliminary study looked at the clinical and MRI effects of daclizumab, a monoclonal antibody, in a small group of people with active relapsing MS despite interferon. Results were encouraging, showing a reduction in MRI active lesions and an improvement in clinical scores. Larger studies are now needed.

authors: Rose JW, Burns JB, Bjorklund J, Klein J, Watt HE, Carlson NG.

source: Neurology. 2007 Aug 21;69(8):785-9.

read more

back to top

Tysabri approved by UK government drugs watchdog

source: UK MS Society

NICE, the UK government drugs watchdog, has published final guidance recommending that Tysabri should be available on the NHS for people with rapidly evolving, severe, relapsing remitting MS.

read more

Small phase 2 study of daclizumab shows benefit alone and in combination with interferon

source: US National MS Society

Researchers report that daclizumab alone or in combination with interferon beta reduced disease activity on MRI and improved symptoms in nine people with relapsing-remitting multiple sclerosis.

read more

New Zealand MS Awareness Week

The New Zealand MS Society's Awareness Week takes place 3-9 September 2007.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.